Skip to main content

CAPSTONE INVESTMENT ADVISORS, LLC

Position in BHC — Bausch Health Companies Inc.

CIK 1426196 NEW YORK, NY

Position in BHC

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$492,566
-$157,043 QoQ
Shares Held
91,216
-2.4% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
7 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in BHC Over Time

Shares Held

Position Value (USD)

Derivatives in BHC

reported options exposure · as of Sep 30, 2020
CallValue
$2,519,034
CallShares
162,100
PutValue
$1,805,748
PutShares
116,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CAPSTONE INVESTMENT ADVISORS, LLC holds $5,128,141 across 6 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in BHC

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $492,566 91,216
2025-12-31 $649,609 93,469
2025-09-30 $514,006 79,691
2025-06-30 $352,766 52,968
2023-12-31 $194,709 24,278
2023-06-30 $80,408 10,051
2020-09-30 $2,519,034 162,100
2020-09-30 $1,805,748 116,200
2020-09-30 $388,919 25,027